Hamps Bio Limited IPO (Hamps Bio IPO) Detail
Hamps Bio IPO is being launched as a fixed-price issue, raising ₹6.22 crores through a fresh issuance of 12.2 lakh shares.
The subscription window for the IPO opens on December 13, 2024, and closes on December 17, 2024. The allotment of shares is anticipated to be finalized on December 18, 2024, and the shares are set to list on the BSE SME platform on December 20, 2024.
The IPO is priced at ₹51 per share, with a minimum application requirement of 2,000 shares. For retail investors, the starting investment is ₹102,000, while high-net-worth individuals (HNIs) must apply for at least two lots (4,000 shares), amounting to ₹204,000.
Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. serves as the lead manager for the IPO, with Bigshare Services Pvt. Ltd. as the registrar. Pure Broking is designated as the market maker for this offering.
Hamps Bio IPO Details
| IPO Date | December 13, 2024 to December 17, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 3,136,000 |
| Share holding post issue | 4,356,000 |
| Market Maker portion | 62,000 shares |
Hamps Bio IPO Timeline (Tentative Schedule)
Hamps Bio IPO opens on December 13, 2024, and closes on December 17, 2024.
| IPO Open Date | Friday, December 13, 2024 |
| IPO Close Date | Tuesday, December 17, 2024 |
| Basis of Allotment | Wednesday, December 18, 2024 |
| Initiation of Refunds | Thursday, December 19, 2024 |
| Credit of Shares to Demat | Thursday, December 19, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 17, 2024 |
Hamps Bio IPO Lot Size
Investors are required to bid for a minimum of 2,000 shares, with additional bids in multiples of this lot size. The table below outlines the minimum and maximum investment thresholds for retail investors and HNIs, detailing both the number of shares and the corresponding investment amounts.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| HNI (Min) | 2 | 4,000 | ₹204,000 |
Hamps Bio IPO Promoter Holding
The company’s promoters include Herrik Shah, Shrenik Shah, Pallavi Shah, Mitali Shah, along with Herrik Shah HUF and Shrenik Shah HUF
| Share Holding Pre Issue | 100.00% |
| Share Holding Post Issue | 71.99% |
About Hamps Bio Limited
Founded in 2007, Hamps Bio Limited specializes in the marketing and distribution of a wide range of pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements.
The company operates through a network of over 50 distributors and e-commerce platforms such as Amazon (serving the US, Canada, and EU markets), Flipkart, and Jio Mart. Its pharmaceutical products are distributed across eight states and union territories, while its freeze-dried and frozen product line reaches six countries and 22 states and union territories.
Business Segments:
- Pharmaceuticals
Hamps Bio markets its pharmaceutical products under the “Hamps” brand. The portfolio includes tablets, syrups, capsules, injectables, and powders. - Freeze-dried and Frozen Products
The FMCG segment operates under the “FzyEzy” brand, focusing on freeze-dried and frozen items. Products include strawberries, jamun, mango, beet powder, chikoo powder, and more. The company employs both B2B and B2C models, selling products under its brand and through contract manufacturing.
Across both divisions, the company offers a portfolio of over 180 products. As of October 31, 2024, Hamps Bio had a workforce of 78 employees.
Competitive Strengths:
- Experienced Leadership: Expertise in strategic business growth within the industry.
- Robust Distribution Network: Strong presence across physical and e-commerce channels.
- Extensive Product Range: A diverse lineup catering to varied customer needs.
- Global Customer Base: Long-standing relationships with a wide and diverse clientele.
- Geographical Reach: Broad presence across domestic and international markets.
- Established Brand Identity: Strong brand recognition in key market segments.
Hamps Bio Limited Financial Information (Restated)
Hamps Bio Limited recorded a 16.41% growth in revenue and a 39.47% increase in profit after tax (PAT) between the financial years ending March 31, 2023, and March 31, 2024.
| Period Ended | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 644.00 | 514.77 | 395.87 | 364.31 |
| Revenue | 436.42 | 650.13 | 558.49 | 534.46 |
| Profit After Tax | 34.08 | 50.07 | 35.90 | 12.15 |
| Net Worth | 370.78 | 337.42 | 136.30 | 100.57 |
| Reserves and Surplus | 57.18 | 141.42 | -13.70 | -49.43 |
| Total Borrowing | 138.31 | 104.52 | 173.77 | 204.31 |
| Amount in ₹ Lakhs | ||||
Key Performance Indicator
The market capitalization of Hamps Bio IPO is Rs 22.22 Cr.
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| Debt/Equity | 0.31 |
| RoNW | 14.84% |
| P/BV | 2.96 |
| PAT Margin (%) | 7.73 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.6 | 1.34 |
| P/E (x) | 31.94 | 38.03 |
Note:
- The pre-IPO EPS is determined using the pre-issue shareholding as stated in the RHP and the most recent financial year earnings available as of March 31, 2024.
- The post-IPO EPS is calculated using the post-issue shareholding and the annualized financial year earnings as of October 31, 2024, as detailed in the RHP.
Objects of the Issue (Hamps Bio IPO Objectives)
The company plans to allocate its proceeds for the following purposes:
- Acquisition of plant and machinery for the FMCG division
- Increasing brand visibility and awareness
- Meeting general corporate expenses
Keep reading and supporting thezipco!
Disclaimer: This information is provided solely for informational purposes and has been gathered from various online sources. Thezipco does not endorse or recommend any products or services. Please verify all details before making any decisions.
